Catalog Number SP-101 |
Device Problems
Patient-Device Incompatibility (2682); Compatibility Problem (2960)
|
Patient Problem
Granuloma (1876)
|
Event Date 02/06/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Physician used venaseal occluding device to treat the patient's entire great saphenous vein (gsv).Ifu was followed.A guide wire was used for the insertion of the catheter.It was reported that at patient follow up approximately 7 weeks post procedure, a granuloma was observed.The granuloma has been removed in a new procedure with venaseal.There was no further patient injury reported.
|
|
Manufacturer Narrative
|
Additional information: during index procedure, local anesthesia was used and compression was performed with the transducer.The catheter tip was located 5cm caudal to the saphenofemoral junction (sfj) prior to initial delivery of adhesive.The venaseal procedure was completed without issue and the vein closed.The granuloma was removed through a small incision in a separate procedure.No additional venaseal treatment was performed as was originally reported.The patient is doing well.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Additional information: the pathology report confirms the presence of non-malignant fibrinoid material in the excised granuloma.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|